Patent details

EP4161528 Title: COMBINATION OF RUXOLITINIB WITH INCB057643 FOR USE IN THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS

Basic Information

Publication number:
EP4161528
PCT Application Number:
US2020050753
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207812025
PCT Publication Number:
WO2021247064
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF RUXOLITINIB WITH INCB057643 FOR USE IN THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
French Title of Invention:
COMBINAISON DE RUXOLITINIB AVEC INCB057643 POUR L'UTILISATION DANS LE TRAITEMENT DE NÉOPLASMES MYÉLOPROLIFÉRATIFS
German Title of Invention:
KOMBINATION VON RUXOLITINIB MIT INCB057643 ZUR VERWENDUNG BEI DER BEHANDLUNG VON MYELOPROLIFERATIVEN NEOPLASMEN
SPC Number:

Dates

Filing date:
14/09/2020
Grant date:
05/11/2025
EP Publication Date:
12/04/2023
PCT Publication Date:
09/12/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/11/2025
EP B1 Publication Date:
05/11/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/09/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/10/2025
 
 

Name:
Incyte Corporation
Address:
1801 Augustine Cut-Off, Wilmington, DE 19803, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
10/11/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LIU, Phillip C.
Address:
United States (US)

2

Name:
STUBBS, Matthew
Address:
United States (US)

Priority

Priority Number:
202063034214 P
Priority Date:
03/06/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/538; A61K 31/519; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202545
Publication date:
05/11/2025
Description:
Grant (B1)

2

Issue number:
202548
Publication date:
26/11/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
11/11/2025 Outgoing Correspondence 1
10/11/2025 Power Of Attorney 1